Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01524133 · ClinicalTrials.gov registry record · Phase 4
PROlonGed ExpoSure Sertraline
A Phase 4 study, sponsored by VA Ann Arbor Healthcare System.
- Completed
- Registry status
- Phase 4
- Development phase
- 223
- Enrollment target
NCT01524133 is a Phase 4 study that has completed, run by VA Ann Arbor Healthcare System. The registered enrollment target is 223 participants.
The verdict
NCT01524133, a Phase 4 study, has completed, sponsored by VA Ann Arbor Healthcare System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 223 participants
- Enrollment target
Study Summary
The current research study aims to compare the effectiveness of two proven treatments for posttraumatic stress disorder (PTSD): Prolonged Exposure (PE), sertraline, and their combination. In addition, the investigators are examining predictors of response to these two treatments and how PTSD symptoms, thoughts, and biological factors may be changed by such treatments. Biological mechanisms of change are also examined including emotion processing and regulation in fMRI, HPA axis function, and genetics and genomics. In addition, the investigators will examine acceptability of each treatment and reasons for ending treatment.
Interventions
- BEHAVIORAL Prolonged Exposure Therapy
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2011-11 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01524133
The ClinicalTrials.gov registry entry for NCT01524133 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Ann Arbor Healthcare System, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolonged Exposure Therapy is the first listed.
NCT01524133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01524133 about?
NCT01524133 is a clinical study titled "PROlonGed ExpoSure Sertraline". The current research study aims to compare the effectiveness of two proven treatments for posttraumatic stress disorder (PTSD): Prolonged Exposure (PE), sertraline, and their combination. In addition, the investigators are examining predictors of response to these two treatments and how PTSD symptom...
What is the current status of trial NCT01524133?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 223 participants. The study started on 2011-11. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01524133?
The interventions under investigation include: Prolonged Exposure Therapy (BEHAVIORAL), Sertraline (DRUG).
Who is sponsoring clinical trial NCT01524133?
This trial is sponsored by VA Ann Arbor Healthcare System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.